TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

Patrick W. Serruys; Carlos Collet; Yoshinobu Onuma; Marie‐Angèle Morel; Ovidiu Dressler; Yiran Zhang; Martin B. Leon; Marie‐Claude Morice; Philippe Généreux; David E. Kandzari; A. Pieter Kappetein; Joseph F. Sabik; Gregg W. Stone

doi:10.1016/j.jacc.2017.09.298

Related publications

Article2022

TCTAP A-028 Predicted and Observed Mortality at 10-Year in Patients With Bifurcation Lesion in the SYNTAX Trial

Kai Ninomiya, Patrick W. Serruys, Shinichiro Masuda, Francesco Burzotta, Marie‐Claude Morice, Michael J. Mack, David R. Holmes, Yoshinobu Onuma

Journal of the American College of Cardiology

Article2022

TCTAP A-026 Impact of Geographic Disparity on 10-Year Mortality in the SYNTAXES Trial, According to the SYNTAX Score II 2020 and Applying Machine Learning (Gradient Boosting Model)

Shigetaka Kageyama, Kai Ninomiya, Shinichiro Masuda, Nozomi Kotoku, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2018

TCT-191 Impact of post-procedural minimal stent area by IVUS on 2-year outcome after PCI in the SYNTAX II trial.

Yuki Katagiri, Giovanni Luigi De Maria, Norihiro Kogame, Javier Escaned, Carlos Collet, Nicola Ryan, Simon Walsh, Manel Sabaté, Justin E. Davies, Maciej Lesiak, Raúl Moreno, Ignacio Cruz‐González, Stephan P Hoole, Nick E.J. West, Jan J. Piek, Azfar Zaman, Rod Stables, Clare Appleby, Nicolas M. Van Mieghem, Neal Uren, Javier Zueco, Paweł Buszman, David Hildick‐Smith, Andrzej Ochała,

Article2018

TCT-322 Agreement between coronary CTA and conventional angiography on the SYNTAX score tertiles stratified by anatomical complexity in the SYNTAX III Revolution trial

Carlos Collet, Daniele Andreini, Ulf Teichgräber, Torsten Doenst, Holger H. Sigusch, Jasmina Alibegovic, Robert Manka, André Plass, Ahmed Ouda, Dries Belsack, Jens Czapla, Stijn Lochy, Danny Schoors, Yoshinobu Onuma, Patrick W. Serruys, Antonio L. Bartorelli

Journal of the American College of Cardiology

Article2018

TCT-309 Angiography-derived fractional flow reserve in the SYNTAX II trial: diagnostic accuracy of QFR and clinical prognostic value of functional SYNTAX score derived from QFR

Taku Asano, Yuki Katagiri, Chun Chin Chang, Norihiro Kogame, Ply Chichareon, Kuniaki Takahashi, Rodrigo Modolo, Erhan Tenekecioğlu, Carlos Collet, Vasim Farooq, Javier Escaned, Adrian Banning, Patrick W. Serruys, Yoshinobu Onuma

Journal of the American College of Cardiology

TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial

Abstract

Discussion(0)

Related publications

TCTAP A-028 Predicted and Observed Mortality at 10-Year in Patients With Bifurcation Lesion in the SYNTAX Trial

TCTAP A-026 Impact of Geographic Disparity on 10-Year Mortality in the SYNTAXES Trial, According to the SYNTAX Score II 2020 and Applying Machine Learning (Gradient Boosting Model)

TCT-191 Impact of post-procedural minimal stent area by IVUS on 2-year outcome after PCI in the SYNTAX II trial.

TCT-322 Agreement between coronary CTA and conventional angiography on the SYNTAX score tertiles stratified by anatomical complexity in the SYNTAX III Revolution trial

TCT-309 Angiography-derived fractional flow reserve in the SYNTAX II trial: diagnostic accuracy of QFR and clinical prognostic value of functional SYNTAX score derived from QFR